Application of QuantiGene nucleic acid quantification technology for high throughput screening

Area of Science:

• Molecular Biology
• Biotechnology
• Assay Development

Background:

• Interleukin-8 (IL-8) plays a key role in inflammatory responses.
• Identifying inhibitors of IL-8 production is crucial for developing new therapeutics.
• Existing methods for measuring IL-8 mRNA can be time-consuming and complex.

Purpose of the Study:

• To develop a high-throughput assay for quantifying interleukin-8 (IL-8) mRNA.
• To evaluate the utility of branched-chain DNA (bDNA) technology for direct mRNA measurement.
• To establish a sensitive and reproducible screening method for IL-8 production inhibitors.

Main Methods:

• Development of a high-throughput assay utilizing the QuantiGene nucleic acid quantification kit.
• Design and synthesis of molecular probes specific for IL-8 mRNA.
• Measurement of IL-8 mRNA in a human lung epithelial cell line stimulated with interleukin-1alpha (IL-1alpha) using bDNA technology.

Main Results:

• The QuantiGene assay directly measures IL-8 mRNA using signal amplification, unlike target amplification methods.
• The assay demonstrated high sensitivity, flexibility, and reproducibility.
• Achieved sensitivity equivalent to or better than promoter-reporter assays, while reducing development time.

Conclusions:

• Branched-chain DNA (bDNA) technology is a viable and efficient method for direct mRNA quantification.
• The developed QuantiGene assay is suitable for high-throughput screening of IL-8 production inhibitors.
• This approach offers a faster and potentially more sensitive alternative to traditional reporter gene assays.